(Q37472042)

20 August 2017

1 reference

title

Role of carvedilol controlled-release in cardiovascular disease (English)

1 reference

20 August 2017

main subject

cardiovascular disease

1 reference

1 reference

1

Gregg C Fonarow

1 reference

20 August 2017

publication date

1 May 2009

1 reference

Expert Review of Cardiovascular Therapy

20 August 2017

published in

1 reference

20 August 2017

volume

7

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

483-498

1 reference

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

20 August 2017

cites work

1 reference

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).

21 January 2018

1 reference

Implantable defibrillators and sudden cardiac death

21 January 2018

1 reference

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection

21 January 2018

1 reference

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

21 January 2018

1 reference

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

21 January 2018

1 reference

Mechanism of action of beta-blocking agents in heart failure

21 January 2018

1 reference

The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.

21 January 2018

1 reference

Initial treatment of hypertension

21 January 2018

1 reference

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

21 January 2018

1 reference

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study

21 January 2018

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

21 January 2018

1 reference

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

21 January 2018

1 reference

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

21 January 2018

1 reference

Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion

21 January 2018

1 reference

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

21 January 2018

1 reference

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

21 January 2018

1 reference

International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey

21 January 2018

1 reference

Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure

21 January 2018

1 reference

The benefit of implementing a heart failure disease management program

21 January 2018

1 reference

Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure

21 January 2018

1 reference

Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial

21 January 2018

1 reference

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design

21 January 2018

1 reference

Association between performance measures and clinical outcomes for patients hospitalized with heart failure

21 January 2018

1 reference

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study

21 January 2018

1 reference

The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001.

21 January 2018

1 reference

Negotiating compliance in heart failure: remaining issues and questions

21 January 2018

1 reference

Treatment adherence and risk of death after a myocardial infarction

21 January 2018

1 reference

Profile of carvedilol controlled-release: a new once-daily formulation of carvedilol

21 January 2018

1 reference

Comparison of once daily versus twice daily oral nitrates in stable angina pectoris

21 January 2018

1 reference

National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance

21 January 2018

1 reference

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study

21 January 2018

1 reference

Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 Study

21 January 2018

1 reference

Implementation of beta-blockade in elderly heart failure patients: role of the nurse specialist.

21 January 2018

1 reference

Beta-blocker dosing in community-based treatment of heart failure.

21 January 2018

1 reference

Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry

21 January 2018

1 reference

Cardioprotection: the role of beta-blocker therapy

21 January 2018

1 reference

beta-Blockers in hypertension: is carvedilol different?

21 January 2018

1 reference

Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial

21 January 2018

1 reference

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

Carvedilol: a nonselective beta blocking agent with antioxidant properties

21 January 2018

1 reference

Vasodilating beta-adrenoceptor blockers as cardiovascular therapeutics

21 January 2018

1 reference

Antioxidant activity of carvedilol in cardiovascular disease

21 January 2018

1 reference

The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients

21 January 2018

1 reference

Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension

21 January 2018

1 reference

Carvedilol decreases elevated oxidative stress in human failing myocardium

21 January 2018

1 reference

Pharmacokinetic properties of a new controlled-release formulation of carvedilol

21 January 2018

1 reference

Ethanol does not alter the pharmacokinetic profile of the controlled-release formulation of carvedilol

21 January 2018

1 reference

Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics

21 January 2018

1 reference

Atenolol in hypertension: is it a wise choice?

21 January 2018

1 reference

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

21 January 2018

1 reference

Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus

21 January 2018

1 reference

After myocardial infarction carvedilol improves insulin resistance compared to metoprolol.

21 January 2018

1 reference

Interactions of glucose metabolism and chronic heart failure

21 January 2018

1 reference

Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure

21 January 2018

1 reference

Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.

21 January 2018

1 reference

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).

21 January 2018

1 reference

Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure

21 January 2018

1 reference

Beta blockers and glucose metabolism in chronic heart failure: friend or foe?

21 January 2018

1 reference

Catabolism in chronic heart failure

21 January 2018

1 reference

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

21 January 2018

1 reference

Risk factor paradox in wasting diseases

21 January 2018

1 reference

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

21 January 2018

1 reference

Obesity paradox as a component of reverse epidemiology in heart failure

21 January 2018

1 reference

Does body mass index really matter in the management of heart failure?: a review of the literature

21 January 2018

1 reference

The relationship between body mass index/body composition and survival in patients with heart failure.

21 January 2018

1 reference

Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure

21 January 2018

1 reference

Renal and cardiac function during alpha1-beta-blockade in congestive heart failure

21 January 2018

1 reference

Cardiovascular protection using beta-blockers: a critical review of the evidence

21 January 2018

1 reference

Tolerability of carvedilol in heart failure: clinical trials experience

21 January 2018

1 reference

Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).

21 January 2018

1 reference

Baseline predictors of tolerability to carvedilol in patients with chronic heart failure

21 January 2018

1 reference

Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study

21 January 2018

1 reference

Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial

21 January 2018

1 reference

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy

21 January 2018

1 reference

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.

21 January 2018

1 reference

Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol

21 January 2018

1 reference

The vasodilatory beta-blockers

21 January 2018

1 reference

COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure

21 January 2018

1 reference

Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, beta-interferon study, BACH, and ATHENA.

21 January 2018

1 reference

Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review

21 January 2018

1 reference

Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure

21 January 2018

1 reference

Switching Between Beta Blockers in Heart Failure Patients: Rationale and Practical Considerations

21 January 2018

1 reference

Practical considerations of beta-blockade in the management of the post-myocardial infarction patient

21 January 2018

1 reference

Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure

21 January 2018

1 reference

Long-Term Trends in the Incidence of and Survival with Heart Failure

21 January 2018

1 reference

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

21 January 2018

1 reference

21 January 2018

1 reference

Improving Guideline Adherence

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.09.15

1 reference

20 August 2017

1 reference